Trial
NCT03346538
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Tanabe Pharma Corporation
Collaborators
—
Condition
Acute Ischemic Stroke
Intervention
Continuous infusion high-dose MCI-186
Why stopped
Business objectives have changed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22